Description:
GOG-0240 Cycle Dose Drug Form (Form D2R) Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer NCT00803062 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4580B20A-FA66-2748-E044-0003BA3F9857
Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4580B20A-FA66-2748-E044-0003BA3F9857
Keywords:
Versions (3) ▾
Uploaded on:
January 9, 2015
DOI:
No DOI assigned. To request one please log in.License:
Creative Commons BY-NC 3.0 LegacyModel comments:
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for:
Item comments for:
In order to download data models you must be logged in. Please log in or register for free.
Cycle Dose Drug Form (D2R) Cervical Cancer (NCT00803062)
- StudyEvent: GOG-0240 Cycle Dose Drug Form (Form D2R)